Table 1.
Antimicrobial agents eligible for the diagnosis of IVACa.
| Antibiotics | ||
| Amikacin Ampicillin Ampicillin/sulbactam Azithromycin Aztreonam Cefazolin Cefepime Cefotaxime Cefotetan Cefoxitin Ceftaroline Ceftazidime Ceftazidime/avibactam Ceftizoxime Ceftolozane/tazobactam Ceftriaxone Cefuroxime Ciprofloxacin Clarithromycin |
Clindamycin Colistimethate Dalbavancin Doripenem Doxycycline Ertapenem Fosfomycin Gemifloxacin Gentamicin Imipenem/cilastatin Levofloxacin Linezolid Meropenem Metronidazole Minocycline Moxifloxacin Nafcillin Oritavancin Oxacillin |
Penicillin G Piperacillin Piperacillin/tazobactam Polymyxin B Quinupristin/dalfopristin Rifampin Sulfamethoxazole/trimethoprim Sulfisoxazole Tedizolid Telavancin Telithromycin Tetracycline Ticarcillin/clavulanate Tigecycline Tobramycin Vancomycin |
| Antifungals | ||
| Amphotericin B Amphotericin B liposomal Anidulafungin Caspofungin |
Fluconazole Isavuconazonium Itraconazole Micafungin |
Posaconazole Voriconazole |
| Antivirals | ||
| Oseltamivir | Zanamivir | Peramivir |
a
IVAC, infection-related ventilator-associated complication.